Drug Trial Radar · NCT00238732
Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause
Last checked: Nov 20, 2026Latest source record: Dec 28, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
650
Actual
Start
Oct 2005
Primary completion
Not stated
Study completion Mar 2007
Sponsor
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Oct 13, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double
- Primary purpose
- Diagnostic
- Who can join
- Female only, from 40 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Bazedoxifine/conjugated estrogens are effective in the treatment of vaginal atrophy.
Conditions
- Vaginal Atrophy
Interventions
Bazedoxifene/Conjugated EstrogenDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Superficial cells (by cervical/vaginal cytologic smear) at screening, and weeks 4 and 12.
- Parabasal cells (by cervical/vaginal cytologic smear) at screening, and weeks 4 and 12.
Locations
63 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Montgomery, Alabama
Site not named
Scottsdale, Arizona
Site not named
Tucson, Arizona
Site not named
Oakland, California
Site not named
San Diego, California
Site not named
Upland, California
Site not named
Denver, Colorado
Site not named
Avon, Connecticut
Site not named
Groton, Connecticut
Site not named
Waterbury, Connecticut
Site not named
Aventura, Florida
Site not named
Gainesville, Florida
Site not named
Miami, Florida
Site not named
Palm Harbor, Florida
Site not named
Palm Springs, Florida
Site not named
Pinnellas Park, Florida
Site not named
Stuart, Florida
Site not named
Tampa, Florida
Site not named
West Palm Beach, Florida
Site not named
Atlanta, Georgia
Site not named
Conyers, Georgia
Site not named
Douglasville, Georgia
Site not named
Savannah, Georgia
Site not named
Idaho Falls, Idaho
Site not named
Champaign, Illinois
Site not named
Chicago, Illinois
Site not named
Kansas City, Kansas
Site not named
Shreveport, Louisiana
Site not named
Baltimore, Maryland
Site not named
Ann Arbor, Michigan
Site not named
Booklyn Center, Minnesota
Site not named
Chaska, Minnesota
Site not named
Jackson, Mississippi
Site not named
Kansas, Mississippi
Site not named
Creve Cour, Missouri
Site not named
St Louis, Missouri
Site not named
Lebanon, New Hampshire
Site not named
Livingston, New Jersey
Site not named
New Brunswick, New Jersey
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.